FDA Brief

Warning letters Drugs

FDA warning letter to

The Platinum Healthcare LLC

High riskIssued Oct 1Posted Oct 6Center for Drug Evaluation and Research (CDER)

The Platinum Healthcare LLC sells unapproved new drugs 'Sycosis' and 'Syphillinum' online for STIs, FDA warns.

What happened

FDA reviewed the company's website, https://platinumwellnesscenter.org/, in July 2026. It found 'Sycosis' and 'Syphillinum' available for purchase with labeling claims about gonorrhea and syphilis 'miasm.' FDA says the products are unapproved new drugs marketed for STIs and their symptoms.

What FDA found

  1. The website labeling makes 'Sycosis' and 'Syphillinum' drugs because it says they are intended to treat disease.

    FD&C Act section 201(g)(1), 21 U.S.C. 321(g)(1)
  2. The products are 'new drugs' because FDA does not generally recognize them as safe and effective for their labeled uses.

    FD&C Act section 201(p), 21 U.S.C. 321(p)
  3. The company introduces or delivers the unapproved new drugs into interstate commerce without FDA-approved applications.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d) and 355(a)

What FDA wants

FDA tells the company to promptly correct the violations and send a written response to FDAAdvisory@fda.hhs.gov within 15 business days of receipt of the letter, including steps taken, steps to prevent recurrence, and related documentation, with reference number 735147 in the subject line.

Who should pay attention

  • online sellers and marketers of homeopathic drugs
  • clinics and public health teams that manage STI care
  • companies that make STI treatment claims on their websites

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk